Inventor · disambiguated record
Chu-Chung Lin
Also filed as: LIN CHU-CHUNG
12 granted patents·6 pending applications·52 citations·filing 2002–2020
87Inventor score
Top patents by PatentIndex Score
18 records- 0190US10004719B1Solid dispersion formulationTAIGEN BIOTECHNOLOGY CO LTD·Filed 2017·Granted Jun 26, 2018·12 cites·29 claims
- 0281US6903104B2Indol-3-YL-2-oxoacetamide compounds and methods of use thereofNAT HEALTH RESEARCH INSTITUTES·Filed 2002·Granted Jun 7, 2005·15 cites·15 claims
- 0379US7396838B2Use of 1H-indol-3-yl-2-oxoacetamide compoundsNAT HEALTH RESEARCH INSTITUTES·Filed 2005·Granted Jul 8, 2008·2 cites·8 claims
- 0478US7183413B2Aminoquinoline compoundsTAIGEN BIOTECHNOLOGY CO LTD·Filed 2004·Granted Feb 27, 2007·18 cites·46 claims
- 0573US10596171B2Cap-dependent endonuclease inhibitorsTAIGEN BIOTECHNOLOGY CO LTD·Filed 2019·Granted Mar 24, 2020·2 cites·18 claims
- 0669US8389560B2HCV protease inhibitorsLIU CHEN-FU·Filed 2009·Granted Mar 5, 2013·2 cites·28 claims
- 0765US7662834B2Methods of 1H-indol-3-yl-2-oxoacetamide compoundsNAT HEALTH RESEARCH INSTITUTES·Filed 2008·Granted Feb 16, 2010·0 cites·14 claims
- 0860US7569596B2Imidazolamino compoundsNAT HEALTH RESEARCH INSTITUTES·Filed 2006·Granted Aug 4, 2009·0 cites·10 claims
- 0960US7462723B2Imidazolamino compoundsNAT HEALTH RESEARCH INSTITUTES·Filed 2006·Granted Dec 9, 2008·0 cites·11 claims
- 1056US7378524B2Aminoquinoline compoundsTAIGEN BIOTECHNOLOGY CO LTD·Filed 2004·Granted May 27, 2008·1 cites·11 claims
- 1150US7109227B2Imidazolamino compoundsNAT HEALTH RESEARCH INSTITUTES·Filed 2003·Granted Sep 19, 2006·0 cites·13 claims
- 1249US10377714B2Trans-isomeric heterocyclic compounds and preparation thereofTAIGEN BIOTECHNOLOGY CO LTD·Filed 2017·Granted Aug 13, 2019·0 cites·28 claims
- 1348US2024101527A1Quinolone carboxylic derivativesTAIGEN BIOTECHNOLOGY CO LTD·Filed 2020·Application pending·0 cites
- 1447US2023012560A1Hepatitis b antiviral agentsTAIGEN BIOTECHNOLOGY CO LTD·Filed 2020·Application pending·0 cites
- 1543US2008108632A1Hcv protease inhibitorsTAIGEN BIOTECHNOLOGY CO LTD·Filed 2007·Application pending·0 cites
- 1643US2009286814A1Hcv protease inhibitorsTAIGEN BIOTECHNOLOGY CO LTD·Filed 2008·Application pending·0 cites
- 1741US2009111757A1Hcv protease inhibitorsTAIGEN BIOTECHNOLOGY CO LTD·Filed 2008·Application pending·0 cites
- 1840US2006036093A1Pyrimidinone compoundsTAIGEN BIOTECHNOLOGY CO LTD·Filed 2005·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Chu-Chung Lin files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →